PERFUSIO CORP.
GREENVILLE, NC · Founded 2014 · CIK 0001657580 · Medtech · Private
Non-invasive wearable or point-of-care device for continuous cardiovascular status monitoring and remote patient communication
perfusio.com →- Grants
- $2.5M
- 6 awards
- Sector median: 1
- Raised
- $11M
- 6 Form D · Dec 2024
- 22 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,001,781 | |
| Federal grant | Department of Health and Human Services · Phase I · Point-of-Care Imaging for Cardiovascular Monitoring: Light Energy-Tissue Interactions | $224,869 | |
| Private capital raised | Form D · SEC | $3,500,000 | |
| Private capital raised | Form D · SEC | $868,741 | |
| Federal grant | Department of Health and Human Services · Phase I · Adding SpO2 and Hemoglobin Determinations to Non-Invasive Hemodynamic Monitoring for Healthy Independent Living | $224,841 | |
| Federal grant | Department of Health and Human Services · Phase II · Non-Invasive Physiologic Evaluation of Peripheral Arterial Disease | $963,313 | |
| Federal grant | Department of Health and Human Services · Phase II · Non-Invasive Physiologic Evaluation of Peripheral Arterial Disease | $524,587 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Multi-spectral Physiologic Visualization Imaging For Non-contact, Real-time Capture of Cardiovascular Vital Signs Using a Novel Optical Engineering Design | $259,590 | |
| Private capital raised | Form D · SEC | $1,597,580 | |
| Private capital raised | Form D · SEC | $2,195,656 | |
| Federal grant | Department of Health and Human Services · Phase I · Project MATCH: Multi-spectral AI/ML powered Burn and Wound Evaluation Technology using a Cost-Effective Handheld Device. | $349,910 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1178 | EvoEndo, Inc. | — | $4.7M |
| 1179 | ANALYTICAL DIAGNOSTIC SOLUTIONS INC | — | — |
| 1180 | IMMUNO TECHNOLOGIES INC | — | — |
| 1181 | PERFUSIO CORP. | — | $11M |
| 1182 | INIA BIOSCIENCES, INC. | — | $200K |
| 1183 | INTRINSIC LIFESCIENCES, LLC | — | — |
| 1184 | CubeWorks, Inc. | — | $18M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- JOFFRE ALVAREZExecutive Officer
- RICHARD BALOTDirector · Executive Officer
- Jeffery BashamExecutive Officer
- JEFFERY BASHAMDirector · Executive Officer
- JEFFREY BASHAMExecutive Officer
- Cheng ChenExecutive Officer
- CHENG CHENDirector · Executive Officer
- Thomas FergusonDirector
- THOMAS FERGUSONDirector
- Peter GeigerExecutive Officer
- PETER GEIGERExecutive Officer
- William HodgesDirector
- WILLIAM HODGESDirector · Executive Officer
- DAVID LAVANCEDirector
- KENICHI MATSUMURADirector
- GEORGE MCGINNDirector
- MIKE SNOWDirector
- STEVE TAYLORDirector
- MONTE TUCKERDirector · Executive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.